Multidrug-Resistant Tb Will Rise In India, Says New Study
by The Daily Eye Team May 15 2017, 12:54 pm Estimated Reading Time: 0 mins, 33 secsA month after the Health Ministry set itself the target of eliminating tuberculosis (TB) by 2025, a new study in the medical journal Lancet says that India’s TB crisis is likely to get worse. According to the latest issue of the journal, Multidrug Resistant-Tuberculosis (MDR-TB), a version of the disease where patients do not respond to first-line drugs, will become more common than it is now. The report projects that, by 2040, the percentage of MDR-TB will make up 32.5% of all TB cases in Russia, 12.4% of the TB cases in India, 8.9% of the TB cases in the Philippines, and 5.7% of all TB cases in South Africa.